Menopause, the Silver Economy and Workplace Opportunities

As we recognise World Menopause Day, take a moment to consider the economic power, diverse expertise and skills, and incredible societal contributions of the estimated 1.1 billion post-menopausal women worldwide by 2025—a population on-par with China or India, and dwarfing any other country. Indeed, if we want to fuel the vibrant $15 trillion silver economy, societies, governments, and employers must empower older women in the future of work, including solutions that fight stigma and increase workplace support related to menopause.

There is much to do, according to pioneering research by Bank of America, which finds that the workplace impacts of menopause are widespread, costly, and inequitable. In their latest report, Break through the stigma: Menopause in the workplace – which follows Bank of America’s previous thought leadership on employer conversations like elder caregiving and Alzheimer’s disease – half of surveyed women said menopause has had a negative impact on their work life. One recent study pegged the cost at $1.8 billion in the U.S. alone, not to mention Europe, Japan, and other super-aged or fast-ageing societies of the OECD.

Yet many of these adverse impacts are avoidable – and can even be transformed into positive outcomes. There are proven benefits to support women at work during menopause, including access to menopause health professionals, coverage for hormone replacement therapy, and policies like time-off or flexible work. Most women who have access to and take advantage of these benefits say they have a positive effect, and, in fact, many employers say they already offer these benefits.

So, what’s the problem? According to Lorna Sabbia, Managing Director, Head of Retirement & Personal Wealth Solutions at Bank of America, stigma is to blame: “Approximately 1.3 million women in the U.S. will enter menopause each year and 20% of the workforce are in some phase of the menopause transition, yet the word ‘menopause’ is rarely uttered, and seldom heard, in workplaces across the country. Often felt to be ‘too personal’ or ‘taboo,’ employees and employers are simply not talking about it.”

Just consider that 76 per cent of HR benefit managers said they discuss menopause-related issues with employees – but only three per cent of employees agreed.

Clearly, employers, policymakers, communities, and society at large need to step up our response to not only develop better solutions, but also ensure women can easily discuss, find, and use those solutions. That will unlock wide-reaching benefits for stronger economies, better women’s health, including follow-on consequences such as osteoporosis and related fractures, and a more dynamic future of work.

First, as populations age, it’s increasingly imperative to help older workers (55+) stay healthy, active, and engaged for longer. Menopause-related benefits should be an important part of the response, alongside support for employee-caregivers (the majority of women), lifelong learning initiatives, and other programmes for the multi-generational workforce. This also fits with the U.N. Decade of Healthy Ageing and its pillars of age-friendly communities, campaigns against ageism, integrated care, and access to long-term care.

Second, greater employer and policy support around menopause are essential for women’s health overall. In the past, the discussion has centered on younger women, but it’s long past time to include the older women who make up an increasing – and increasingly vital – share of aging societies. This would bolster health equity, not just across gender but also across age.

Third, the link to bone health, osteoporosis, and fragility fractures is key and another important opportunity to mitigate soaring impacts and costs. By 2025, it’s estimated that around 13.5 million older people will suffer fragility fractures each year, at an annual cost of ~$400 billion. Yet a staggering 80 per cent are not diagnosed and treated with effective therapies, including to prevent the second fracture that is often especially devastating, life-threatening, and expensive.

Benefits for menopause should be seen as one part of a larger bone health response, reaching from early awareness through osteoporosis screening, diagnosis, and support for Fracture Liaison Services.  Japan has taken the lead here, when in April ’22 they reformed their access and reimbursement for Fracture Liaison Services to help address second fractures; leaders in Super-Ageing Japan know the linkages to healthier ageing, including bone health, economic growth and the silver economy.

Finally, robust employer support will empower and equip older women for the future of the workplace and the workforce. Even more than AI, hybrid work, or other buzzy topics, the future of work will be defined by our ability to adapt for a world, and a workforce, with more old than young. Leaders and experts on ageing recognise the importance of this topic, which the Global Coalition on Aging (GCOA) will feature at our High-Level Forum on the Silver Economy this December.

Indeed, as the leading business voice on aging-related policy and strategy, GCOA is prioritising the decisive role of women in the global response to ageing. That’s why we plan to plan to launch a new platform, Women in the Silver Economy (WISE) Council, dedicated to collaboration, knowledge-sharing, and solutions. We know that advances here – including for menopause – will amplify across more innovative companies, more dynamic workforces, and more prosperous and age-friendly communities.

Source: OECD Forum

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.